Paper Details

  1. Home
  2. Paper Details

Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis.

Author: BermetzLilian, EggerMatthias, LourençoTania, LowNicola, RobertNadège, RutjesAnne W S, ScottPippa, ScottSusana

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Both 3-dose and 2-dose pneumococcal conjugate vaccine (PCV) schedules resulted in high levels of seropositivity, with small differences favoring the 3-dose schedule. However, clinical outcome data from randomized controlled trials with direct comparisons of different PCV schedules is lacking.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses in infancy and a booster dose. The evidence for the effects of different schedules was examined in this systematic review and meta-analysis. METHODS: We searched 12 databases and trial registers up to...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.vaccine.2011.07.042

データ提供：米国国立医学図書館（NLM）

Comparing Pneumococcal Conjugate Vaccine Schedules

In the world of immunology, we're constantly striving to optimize vaccine schedules to ensure maximum protection against infectious diseases. This research takes a deep dive into the effectiveness of different pneumococcal conjugate vaccine (PCV) schedules, exploring the relative benefits of different dosing regimens. It's like carefully navigating a complex desert oasis, seeking the most effective routes to reach a desired destination.

This systematic review and meta-analysis compared the effectiveness of different PCV schedules based on the number of primary doses (2 or 3) and whether or not a booster dose was included. The researchers analyzed data from multiple studies to determine the impact of these different schedules on serological response, nasopharyngeal carriage, and clinical outcomes. It's like meticulously comparing different paths through the desert, considering factors such as terrain, water sources, and potential hazards.

The findings suggest that both 3-dose and 2-dose schedules resulted in high levels of seropositivity, but 3-dose schedules tended to be slightly more effective, particularly for certain serotypes. This is like discovering that different desert trails might lead to the same oasis, but some routes might offer better protection against sandstorms or other hazards along the way.

Seropositivity and Vaccine Effectiveness

This study underscores the importance of understanding the specific characteristics of different PCV schedules and their impact on immune response. It's like recognizing that different desert oases might have varying levels of water and resources, requiring careful consideration to choose the most appropriate path for a successful journey.

Vaccination Strategies and Public Health

The findings of this study contribute to the ongoing development of optimal vaccination strategies for pneumococcal disease. It's like continuously refining our understanding of the desert landscape, ensuring that we can navigate it with confidence and effectiveness.

Dr.Camel's Conclusion

This study, like a compass guiding us through the complex world of vaccination strategies, provides valuable insights into the effectiveness of different PCV schedules. It emphasizes the importance of evidence-based decision making and continuous refinement of our understanding to ensure optimal protection against disease.

Date :
  1. Date Completed 2012-03-21
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

21821080

DOI: Digital Object Identifier

10.1016/j.vaccine.2011.07.042

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.